IRIS
AIUTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.696
EU - Europa 2.593
AS - Asia 2.132
SA - Sud America 321
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 16.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.635
SG - Singapore 946
DE - Germania 880
CN - Cina 478
RU - Federazione Russa 337
IT - Italia 272
BR - Brasile 254
HK - Hong Kong 251
GB - Regno Unito 225
UA - Ucraina 221
IE - Irlanda 186
VN - Vietnam 164
FR - Francia 138
FI - Finlandia 90
SE - Svezia 88
JP - Giappone 55
KR - Corea 43
IN - India 38
CA - Canada 37
ES - Italia 32
AR - Argentina 29
NL - Olanda 26
AT - Austria 22
ID - Indonesia 22
IQ - Iraq 22
MX - Messico 21
TR - Turchia 21
BE - Belgio 19
PL - Polonia 18
BD - Bangladesh 17
ZA - Sudafrica 14
EC - Ecuador 12
UZ - Uzbekistan 9
IR - Iran 8
SA - Arabia Saudita 8
CL - Cile 7
PE - Perù 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
KG - Kirghizistan 6
LT - Lituania 6
PH - Filippine 6
PY - Paraguay 5
AZ - Azerbaigian 4
EU - Europa 4
IL - Israele 4
KE - Kenya 4
MY - Malesia 4
AU - Australia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
JO - Giordania 3
MA - Marocco 3
RO - Romania 3
RS - Serbia 3
VE - Venezuela 3
AL - Albania 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
EG - Egitto 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
CG - Congo 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
Totale 16.781
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.527
Wilmington 2.525
Houston 2.398
Fairfield 620
Singapore 560
Ann Arbor 389
Ashburn 383
Chandler 258
Hong Kong 244
San Jose 238
Seattle 238
Cambridge 192
Jacksonville 192
Beijing 188
Dublin 170
Medford 124
Santa Clara 101
Dearborn 89
Rome 86
Council Bluffs 56
The Dalles 54
Lawrence 51
Buffalo 49
Tokyo 48
Los Angeles 46
New York 46
Ho Chi Minh City 44
Lauterbourg 42
Menlo Park 41
Hanoi 40
Munich 40
Helsinki 36
Zhengzhou 33
Moscow 31
San Diego 29
Nuremberg 25
São Paulo 25
Dallas 24
Chicago 22
Mülheim 22
Frankfurt am Main 20
Milan 20
Falls Church 18
London 18
Shanghai 18
Brussels 17
Phoenix 17
Boardman 15
Chongqing 15
Nanjing 15
Orem 15
Hefei 14
Redwood City 14
Jakarta 13
Montreal 12
Norwalk 12
San Mateo 12
Toronto 12
Amsterdam 11
Brooklyn 11
North Bergen 11
University Park 11
Vienna 11
Barcelona 10
Da Nang 10
Manchester 10
Najaf 10
Warsaw 10
Chennai 9
Dong Ket 9
Guangzhou 9
Stockholm 9
Boston 8
Johannesburg 8
Rio de Janeiro 8
Ankara 7
Atlanta 7
Belo Horizonte 7
Denver 7
Mexico City 7
Mountain View 7
Poplar 7
Redondo Beach 7
Verona 7
Baghdad 6
Elk Grove Village 6
Engelhard 6
Haiphong 6
Jinan 6
Kunming 6
Naples 6
Roubaix 6
Turku 6
Bexley 5
Buenos Aires 5
Florence 5
Hangzhou 5
Lappeenranta 5
Salvador 5
Shenzhen 5
Totale 12.920
Salva come PNG Salva come JPEG
Nome #
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome. 554
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency 526
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 519
Clinical features and follow-up in patients with 22q11.2 deletion syndrome 496
Chronic Granulomatous Disease Presenting with Salmonella Brain Abscesses. 496
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis 475
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. 474
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency. 455
The Quality of Life of Children and Adolescents with X-Linked Agammaglobulinemia 455
Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases 452
. Early-onset monocyte-B-natural killer-dendritic cells’ deficiency successfully treated with hematopoietic stem cell transaplantation 452
Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID 448
Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients 448
The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function 437
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 434
Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) 428
Successful treatment with percutaneous transhepatic alcoholization of a liver abscess in a child with chronic granulomatous disease 422
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 415
Long-Term Safety and Efficacy of Gene Therapyfor Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency 407
Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency 366
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 320
null 316
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184. 310
JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene 246
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 229
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 225
Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent 214
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 209
ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency 209
Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: Analysis of function and distribution in lymphoid organs 203
How I treat ADA deficiency 198
Comprehensive genomic access to vector integration in clinical gene therapy. 189
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy 186
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID 185
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 185
Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) 181
Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection 179
Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy 175
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency 173
Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID 168
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 165
Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models 163
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. 163
Gene therapy for adenosine deaminase deficiency. 157
Gene therapy for primary immunodeficiencies: Part 1 155
Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome 153
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. 152
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency. 144
New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy. 140
Gene therapy for primary immunodeficiencies: Part 2 138
Retroviral integrations in gene therapy trials 137
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 135
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019) 133
Ten years of gene therapy for primary immuno deficiencies 115
Severe Toxoplasma gondii infection in a member of a NFKB2-deficient family with T and B cell dysfunction 109
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 106
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 100
Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? 91
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 89
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity 88
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 84
SARS-CoV-2-related MIS-C: a key to the viral and genetic causes of Kawasaki disease? 81
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis 76
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 74
Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β 74
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for the diagnosis of inborn errors of immunity (IEI) 70
Studying severe long COVID to understand post-infectious disorders beyond COVID-19 66
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 64
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 61
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 60
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 59
From your nose to your toes: a review of severe acute respiratory syndrome Coronavirus 2 pandemic‒associated pernio 54
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 46
Totale 16.961
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 0 0 0 0 84 107 45
2021/2022660 22 70 28 35 42 48 31 46 77 46 37 178
2022/2023744 83 57 28 82 56 182 71 42 62 10 50 21
2023/2024281 32 26 20 14 35 61 13 19 12 0 7 42
2024/20251.554 53 358 157 93 64 148 158 96 122 101 125 79
2025/20262.596 207 160 311 261 254 117 342 348 333 263 0 0
Totale 16.961